Osteopetrosis

Overexpression Of CREB Protein Plays Pivotal Role In Disease Development

Published in Immunotherapy Weekly, November 14th, 2001

Researchers at Children's Research Institute, located on the campus of Columbus (Ohio) Children's Hospital, designed the first-ever transgenic model (genetically modified) to show how the CREB protein (cyclic AMP response element binding protein) leads to the abnormal function of osteoclasts (cells that break down the bone), resulting in osteopetrosis.

Lead researcher Natarajan Muthusamy, DVM, PhD, presented the findings at the American Academy of Pediatrics (AAP) National Conference and Exhibition in San Francisco, California.

"In our study, we have shown that if the mutant CREB protein is over-expressed, the result is osteopetrosis," said...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Immunotherapy Weekly

Source: Immunotherapy Weekly (2001-11-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry